Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ DuPont de Nemours Inc. (DD) Stock Forecast & Price Prediction United States | NYSE | Basic Materials | Specialty Chemicals
$48.26
+1.42 (3.03%)Did DD Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if DuPont is one of their latest high-conviction picks.
Based on our analysis of 4 Wall Street analysts, DD has a bullish consensus with a median price target of $57.00 (ranging from $52.00 to $64.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $48.26, the median forecast implies a 18.1% upside. This outlook is supported by 13 Buy, 3 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for DD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 11, 2026 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $60.00 |
| May 6, 2026 | UBS | Joshua Spector | Buy | Maintains | $59.00 |
| Apr 24, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Apr 21, 2026 | B of A Securities | Neutral | Maintains | $N/A | |
| Apr 13, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Feb 18, 2026 | Deutsche Bank | Buy | Maintains | $N/A | |
| Feb 17, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 12, 2026 | BMO Capital | Outperform | Maintains | $N/A | |
| Feb 11, 2026 | Jefferies | Buy | Maintains | $N/A | |
| Feb 11, 2026 | UBS | Buy | Maintains | $N/A | |
| Feb 11, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Feb 11, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Feb 11, 2026 | Keybanc | Overweight | Maintains | $N/A | |
| Jan 21, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Jan 16, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| Jan 9, 2026 | Keybanc | Overweight | Maintains | $N/A | |
| Jan 7, 2026 | UBS | Buy | Maintains | $N/A | |
| Dec 18, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Nov 18, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Nov 7, 2025 | Wells Fargo | Overweight | Maintains | $N/A |
The following stocks are similar to DuPont based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
DuPont de Nemours Inc. has a market capitalization of $19.66B with a P/E ratio of 127.0x. The company generates $6.92B in trailing twelve-month revenue with a -0.4% profit margin.
Revenue growth is +4.3% quarter-over-quarter, while maintaining an operating margin of +13.8% and return on equity of +0.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Specialty chemicals and advanced materials provider.
The company generates revenue by supplying advanced materials, engineered products, and integrated solutions to various industries such as electronics, aerospace, and healthcare. Its offerings focus on improving manufacturing processes, enhancing performance, and providing protective solutions tailored to specific industrial needs.
Headquartered in Wilmington, Delaware, DuPont de Nemours Inc. operates in multiple sectors, ensuring a diversified portfolio that enhances its position in the specialty chemicals market.
Basic Materials
Specialty Chemicals
15,000
Ms. Lori D. Koch
United States
2019
DuPont's U.S. healthcare manufacturing sites now run on renewable electricity, advancing climate goals and lowering emissions.
DD's MemCor MBR tech was chosen for Sydney's Riverstone WRRF upgrade, boosting wastewater capacity to support growth and protect waterways.
DD's MemCor MBR technology will be used in the upgrade of Sydney's Riverstone WRRF, enhancing wastewater capacity to support regional growth and environmental protection.
DD's selection for the Riverstone WRRF upgrade signals demand for innovative wastewater solutions, potentially enhancing revenue and market position amid urban growth.
DuPont's U.S. healthcare manufacturing sites now operate on renewable electricity, supporting climate initiatives and reducing emissions.
DuPont's transition to renewable electricity enhances sustainability, potentially reducing costs and improving public perception, which can boost long-term profitability and attract eco-conscious investors.
DuPont (NYSE: DD) will supply its MemCorโข MBR system for upgrades at the Riverstone Water Resource Recovery Facility in Sydney, enhancing wastewater infrastructure amid regional growth.
DuPont's contract for a major wastewater upgrade in Sydney signals strong demand for water solutions, potentially boosting revenue and market position, which can enhance investor confidence.
DuPont (NYSE:DD) announced that its U.S. healthcare manufacturing facilities are now powered by 100% renewable electricity, supporting its 2035 climate goals.
DuPont's shift to 100% renewable electricity enhances sustainability, potentially reducing costs and improving brand image, which can attract environmentally-conscious investors and boost stock performance.
DuPont (NYSE: DD) approved a 1-for-3 reverse stock split and a reduction in authorized shares, effective immediately.
A reverse stock split can boost share price and attract institutional investors, but may also signal underlying issues. It affects liquidity and market perception of DuPont.
The materials and chemicals company has received approval for a reverse stock split from both shareholders and its board of directors.
A reverse stock split can indicate a company's effort to boost its share price, potentially attracting more institutional investors and improving market perception.
Based on our analysis of 4 Wall Street analysts, DuPont de Nemours Inc. (DD) has a median price target of $57.00. The highest price target is $64.00 and the lowest is $52.00.
According to current analyst ratings, DD has 13 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $48.26. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict DD stock could reach $57.00 in the next 12 months. This represents a 18.1% increase from the current price of $48.26. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by supplying advanced materials, engineered products, and integrated solutions to various industries such as electronics, aerospace, and healthcare. Its offerings focus on improving manufacturing processes, enhancing performance, and providing protective solutions tailored to specific industrial needs.
The highest price target for DD is $64.00 from at , which represents a 32.6% increase from the current price of $48.26.
The lowest price target for DD is $52.00 from at , which represents a 7.7% increase from the current price of $48.26.
The overall analyst consensus for DD is bullish. Out of 4 Wall Street analysts, 13 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $57.00.
Stock price projections, including those for DuPont de Nemours Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.